化学指示インクの世界市場:タイプ別([CBC、HGB / HCT、BMP、BUNクレアチニン、電解質試験、HbA1c試験、包括的代謝パネル、肝臓パネル、腎パネル、脂質パネル)エンドユーザー別、セグメント予測、2013 – 2024...市場調査レポートについてご紹介

【英文タイトル】Clinical Laboratory Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel), By End-use, And Segment Forecasts, 2013 - 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope &Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Clinical Laboratory Testing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rising geriatric population base
3.1.1.2 Growing prevalence of target diseases
3.1.1.3 Introduction of innovative solutions
3.1.1.4 Rising demand for early disease detection
3.1.2 Market restraint analysis
3.1.2.1 Presence of ambiguous regulatory framework
3.2 Penetration & Growth Prospect Mapping
3.3 Clinical Laboratory Test- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Clinical Laboratory Testing Market: Type Estimates & Trend Analysis
4.1 Clinical Laboratory Testing Market: Type movement analysis
4.2 Complete Blood Count
4.2.1 Complete blood count market, 2013 – 2024 (USD Billion)
4.3 HGB/HCT testing
4.3.1 HGB/HCT testing market, 2013 – 2024 (USD Billion)
4.4 Basic Metabolic Panel Testing
4.4.1 Basic metabolic panel testing market, 2013 – 2024 (USD Billion)
4.5 BUN Creatinine Testing
4.5.1 BUN creatinine testing market, 2013 – 2024 (USD Billion)
4.6 Electrolytes Testing
4.6.1 Electrolytes testing market, 2013 – 2024 (USD Billion)
4.7 HbA1c Testing
4.7.1 HbA1c testing market, 2013 – 2024 (USD Billion)
4.8 Comprehensive Metabolic Panel Testing
4.8.1 Comprehensive metabolic panel testing market, 2013 – 2024 (USD Billion)
4.9 Liver Panel Testing
4.9.1 Liver panel testing market, 2013 – 2024 (USD Billion)
4.10 Renal Panel Testing
4.10.1 Renal panel testing market, 2013 – 2024 (USD Billion)
4.11 Lipid Panel Testing
4.11.1 Lipid panel testing market, 2013 – 2024 (USD Billion)
Chapter 5 Clinical Laboratory Testing Market: End-use Estimates & Trend Analysis
5.1 Clinical Laboratory Testing Market: End-use movement analysis
5.2 Primary Clinics
5.2.1 Primary clinics market, 2013 – 2024 (USD Billion)
5.3 Central Laboratories
5.3.1 Central laboratories market, 2013 – 2024 (USD Billion)
Chapter 6 Clinical Laboratory Testing Market: Regional Estimates & Trend Analysis, by Type
6.1 Clinical Laboratory Testing Market Share by Region, 2015 & 2024
6.2 North America
6.2.1 North America clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.3 Europe
6.3.1 Europe Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.3.2 UK
6.3.2.1 UK Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.4.2 Japan
6.4.2.1 Japan Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.4.3 China
6.4.3.1 China Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.4.4 India
6.4.4.1 India Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.5 Latin America
6.5.1 Latin America Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.6 MEA
6.6.1 MEA Clinical laboratory testing market, 2013 – 2024 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa Clinical laboratory testing market, 2013 – 2024 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Abbott Laboratories
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 ARUP Laboratories (Associated Regional & University Pathologists Inc.)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 OPKO Health, Inc. (Bio-Reference Labs)
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Bioscientia Institut für Medizinische Diagnostik GmbH
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Charles River Laboratories International, Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Neogenomics Laboratories, Inc. (Clarient, Inc.)
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Genoptix
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.8 Healthscope
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.9 Labco S.A
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Laboratory Corporation of America Holdings (LabCorp)
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Qiagen N.V
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Quest Diagnostics
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Siemens Healthineers
7.3.13.1 Company overview
7.3.13.2 Financial Performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 Sonic Healthcare Ltd.
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 Spectra Laboratories (Fresenius Medical Care Holdings, Inc.)
7.3.15.1 Company overview
7.3.15.2 Financial Performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Merck KgaA (Merck Millipore Sigma)
7.3.16.1 Company overview
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Tulip Group
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.18 Biosino Bio-technology and Science Inc
7.3.18.1 Company overview
7.3.18.2 Financial performance
7.3.18.3 Product benchmarking
7.3.18.4 Strategic initiatives


【レポート販売概要】

■ タイトル:化学指示インクの世界市場:タイプ別([CBC、HGB / HCT、BMP、BUNクレアチニン、電解質試験、HbA1c試験、包括的代謝パネル、肝臓パネル、腎パネル、脂質パネル)エンドユーザー別、セグメント予測、2013 – 2024
■ 英文:Clinical Laboratory Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel), By End-use, And Segment Forecasts, 2013 - 2024
■ 発行日:2016年12月22日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707186
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。